Comparison Chart PharmaEssentia Corporation LUXEMBOURG S.E.
Stocks
261280558
US7169721047
Biotechnology & Medical Research
|
End-of-day quote
LUXEMBOURG S.E.
14/08/2026
|
5-day change | 1st Jan Change | ||
| 47.00 USD | +4.44% |
|
+22.40% | +247.80% |
| 08-13 | PharmaEssentia Clarifies Report Projecting 2026 Revenue | MT |
| 08-12 | PharmaEssentia Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PHARMAESSENTIA CORPORATION | Bio Therapeutic Drugs | +4.44% | +22.40% | +247.80% | +208.70% | - | 19.43B |
-
|
-
|
-
|
Select your edition
All financial news and data tailored to specific country editions
